The Influence of Different Anthelmintics on the Intestinal Epithelial Tissue of Toxocara Canis (Nematoda)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Full Text in Pdf Format
DISEASES OF AQUATIC ORGANISMS Published July 30 Dis Aquat Org Oral pharmacological treatments for parasitic diseases of rainbow trout Oncorhynchus mykiss. 11: Gyrodactylus sp. J. L. Tojo*, M. T. Santamarina Department of Microbiology and Parasitology, Laboratory of Parasitology, Faculty of Pharmacy, Universidad de Santiago de Compostela, E-15706 Santiago de Compostela, Spain ABSTRACT: A total of 24 drugs were evaluated as regards their efficacy for oral treatment of gyro- dactylosis in rainbow trout Oncorhj~nchusmykiss. In preliminary trials, all drugs were supplied to infected fish at 40 g per kg of feed for 10 d. Twenty-two of the drugs tested (aminosidine, amprolium, benznidazole, b~thionol,chloroquine, diethylcarbamazine, flubendazole, levamisole, mebendazole, n~etronidazole,mclosamide, nitroxynil, oxibendazole, parbendazole, piperazine, praziquantel, roni- dazole, secnidazole, tetramisole, thiophanate, toltrazuril and trichlorfon) were ineffective Triclabenda- zole and nitroscanate completely eliminated the infection. Triclabendazole was effective only at the screening dosage (40 g per kg of feed for 10 d), while nitroscanate was effective at dosages as low as 0.6 g per kg of feed for 1 d. KEY WORDS: Gyrodactylosis . Rainbow trout Treatment. Drugs INTRODUCTION to the hooks of the opisthohaptor or to ulceration as a result of feeding by the parasite. The latter is the most The monogenean genus Gyrodactylus is widespread, serious. though some individual species have a restricted distri- Transmission takes place largely as a result of direct bution. Gyrodactyloses affect numerous freshwater contact between live fishes, though other pathways species including salmonids, cyprinids and ornamen- (contact between a live fish and a dead fish, or with tal fishes, as well as marine fishes including gadids, free-living parasites present in the substrate, or with pleuronectids and gobiids. -
Chemotherapy of Gastrointestinal Helminths
Chemotherapy of Gastrointestinal Helminths Contributors J. H. Arundel • J. H. Boersema • C. F. A. Bruyning • J. H. Cross A. Davis • A. De Muynck • P. G. Janssens • W. S. Kammerer IF. Michel • M.H. Mirck • M.D. Rickard F. Rochette M. M. H. Sewell • H. Vanden Bossche Editors H. Vanden Bossche • D.Thienpont • P.G. Janssens UNIVERSITATS- BlfiUOTHElC Springer-Verlag Berlin Heidelberg New York Tokyo Contents CHAPTER 1 Introduction. A. DAVIS A. Pathogenic Mechanisms in Man 1 B. Modes of Transmission 2 C. Clinical Sequelae of Infection 3 D. Epidemiological Considerations 3 E. Chemotherapy 4 F. Conclusion 5 References 5 CHAPTER 2 Epidemiology of Gastrointestinal Helminths in Human Populations C. F. A. BRUYNING A. Introduction 7 B. Epidemiological or "Mathematical" Models and Control 8 C. Nematodes 11 I. Angiostrongylus costaricensis 11 II. Anisakis marina 12 III. Ascaris lumbricoides 14 IV. Capillaria philippinensis 21 V. Enterobius vermicularis 23 VI. Gnathostoma spinigerum 25 VII. Hookworms: Ancylostoma duodenale and Necator americanus . 26 VIII. Oesophagostoma spp 32 IX. Strongyloides stercoralis 33 X. Ternidens deminutus 34 XI. Trichinella spiralis 35 XII. Trichostrongylus spp 38 XIII. Trichuris trichiura 39 D. Trematodes 41 I. Echinostoma spp 41 II. Fasciolopsis buski 42 III. Gastrodiscoides hominis 44 IV. Heterophyes heterophyes 44 V. Metagonimus yokogawai 46 X Contents E. Cestodes 47 I. Diphyllobothrium latum 47 II. Dipylidium caninum 50 III. Hymenolepis diminuta 51 IV. Hymenolepis nana 52 V. Taenia saginata 54 VI. Taenia solium 57 VII. Cysticercosis cellulosae 58 References 60 CHAPTER 3 Epidemiology and Control of Gastrointestinal Helminths in Domestic Animals J. F. MICHEL. With 20 Figures A. Introduction 67 I. -
Sheet1 Page 1 a Abamectin Acetazolamide Sodium Adenosine-5-Monophosphate Aklomide Albendazole Alfaxalone Aloe Vera Alphadolone A
Sheet1 A Abamectin Acetazolamide sodium Adenosine-5-monophosphate Aklomide Albendazole Alfaxalone Aloe vera Alphadolone Acetate Alpha-galactosidase Altrenogest Amikacin and its salts Aminopentamide Aminopyridine Amitraz Amoxicillin Amphomycin Amphotericin B Ampicillin Amprolium Anethole Apramycin Asiaticoside Atipamezole Avoparcin Azaperone B Bambermycin Bemegride Benazepril Benzathine cloxacillin Benzoyl Peroxide Benzydamine Bephenium Bephenium Hydroxynaphthoate Betamethasone Boldenone undecylenate Boswellin Bromelain Bromhexine 2-Bromo-2-nitropan-1, 3 diol Bunamidine Buquinolate Butamisole Butonate Butorphanol Page 1 Sheet1 C Calcium glucoheptonate (calcium glucoheptogluconate) Calcium levulinate Cambendazole Caprylic/Capric Acid Monoesters Carbadox Carbomycin Carfentanil Carnidazole Carnitine Carprofen Cefadroxil Ceftiofur sodium Centella asiatica Cephaloridine Cephapirin Chlorine dioxide Chlormadinone acetate Chlorophene Chlorothiazide Chlorpromazine HCl Choline Salicylate Chondroitin sulfate Clazuril Clenbuterol Clindamycin Clomipramine Clopidol Cloprostenol Clotrimazole Cloxacillin Colistin sulfate Copper calcium edetate Copper glycinate Coumaphos Cromolyn sodium Crystalline Hydroxycobalamin Cyclizine Cyclosporin A Cyprenorphine HCl Cythioate D Decoquinate Demeclocycline (Demethylchlortetracycline) Page 2 Sheet1 Deslorelin Desoxycorticosterone Pivalate Detomidine Diaveridine Dichlorvos Diclazuril Dicloxacillin Didecyl dimethyl ammonium chloride Diethanolamine Diethylcarbamazine Dihydrochlorothiazide Diidohydroxyquin Dimethylglycine -
(12) United States Patent (10) Patent No.: US 9,173.403 B2 Rosentel, Jr
USOO9173403B2 (12) United States Patent (10) Patent No.: US 9,173.403 B2 Rosentel, Jr. et al. (45) Date of Patent: Nov. 3, 2015 (54) PARASITICIDAL COMPOSITIONS FOREIGN PATENT DOCUMENTS COMPRISING MULTIPLE ACTIVE AGENTS, BR PIO403620 A 3, 2006 METHODS AND USES THEREOF EP 83.6851 A 4f1998 GB 2457734 8, 2009 (75) Inventors: Joseph K. Rosentel, Jr., Johns Creek, WO WO 98,17277 4f1998 GA (US); Monica Tejwani, Monmouth WO WO O2/O94233 11, 2002 WO WO2004/O16252 2, 2004 Junction, NJ (US); Arima Das-Nandy, WO WO 2007/O18659 2, 2007 Titusville, NJ (US) WO WO 2008/O3O385 3, 2008 WO 2008/136791 11, 2008 (73) Assignee: MERLAL, INC., Duluth, GA (US) WO WO 2009/O18198 2, 2009 WO WO 2009/027506 3, 2009 WO 2009/112837 9, 2009 (*) Notice: Subject to any disclaimer, the term of this WO WO 2010/026370 3, 2010 patent is extended or adjusted under 35 WO WO2010.109214 9, 2010 U.S.C. 154(b) by 100 days. OTHER PUBLICATIONS (21) Appl. No.: 13/078,496 Notice of Opposition in the matter of New Zealand Patent Applica (22) Filed: Apr. 1, 2011 tion 595934 in the name of Norbrook Laboratories Limited and Opposition thereto by Merial Limited dated Jun. 28, 2014. (65) Prior Publication Data First Supplementary Notice of Opposition in the matter of New Zealand Patent Application 595934 in the name of Norbrook Labo US 2011 FO245191 A1 Oct. 6, 2011 ratories Limited and Opposition thereto by Merial Limited dated Aug. 28, 2014. Second Supplementary Notice of Opposition in the matter of New Related U.S. -
Addendum A: Antiparasitic Drugs Used for Animals
Addendum A: Antiparasitic Drugs Used for Animals Each product can only be used according to dosages and descriptions given on the leaflet within each package. Table A.1 Selection of drugs against protozoan diseases of dogs and cats (these compounds are not approved in all countries but are often available by import) Dosage (mg/kg Parasites Active compound body weight) Application Isospora species Toltrazuril D: 10.00 1Â per day for 4–5 d; p.o. Toxoplasma gondii Clindamycin D: 12.5 Every 12 h for 2–4 (acute infection) C: 12.5–25 weeks; o. Every 12 h for 2–4 weeks; o. Neospora Clindamycin D: 12.5 2Â per d for 4–8 sp. (systemic + Sulfadiazine/ weeks; o. infection) Trimethoprim Giardia species Fenbendazol D/C: 50.0 1Â per day for 3–5 days; o. Babesia species Imidocarb D: 3–6 Possibly repeat after 12–24 h; s.c. Leishmania species Allopurinol D: 20.0 1Â per day for months up to years; o. Hepatozoon species Imidocarb (I) D: 5.0 (I) + 5.0 (I) 2Â in intervals of + Doxycycline (D) (D) 2 weeks; s.c. plus (D) 2Â per day on 7 days; o. C cat, D dog, d day, kg kilogram, mg milligram, o. orally, s.c. subcutaneously Table A.2 Selection of drugs against nematodes of dogs and cats (unfortunately not effective against a broad spectrum of parasites) Active compounds Trade names Dosage (mg/kg body weight) Application ® Fenbendazole Panacur D: 50.0 for 3 d o. C: 50.0 for 3 d Flubendazole Flubenol® D: 22.0 for 3 d o. -
Stembook 2018.Pdf
The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 WHO/EMP/RHT/TSN/2018.1 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances. Geneva: World Health Organization; 2018 (WHO/EMP/RHT/TSN/2018.1). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. -
Report Contents
Final Report 2011 Veterinary pharmacology curriculum renewal to improve graduate outcomes and public safety Lead institution: The University of Queensland Partners: Australian Veterinary Association Chapter of Veterinary Pharmacology Charles Sturt University James Cook University Massey University (NZ) Murdoch University The University of Melbourne The University of Sydney Authors: Associate Professor Paul Mills Dr Stephen Page Dr Amanda Craig Website: http://vcpn.moodlesites.com/login/index.php Support for this project has been provided by the Australian Learning and Teaching Council Limited, an initiative of the Australian Government Department of Education, Employment and Workplace Relations. The views expressed in this report do not necessarily reflect the views of the Australian Learning and Teaching Council Ltd. This work is published under the terms of the Creative Commons Attribution Noncommercial‐ShareAlike 3.0 Australia Licence. Under this Licence you are free to copy, distribute, display and perform the work and to make derivative works. Attribution: You must attribute the work to the original authors and include the following statement: Support for the original work was provided by the Australian Learning and Teaching Council Ltd, an initiative of the Australian Government Department of Education, Employment and Workplace Relations. Noncommercial: You may not use this work for commercial purposes. Share Alike. If you alter, transform, or build on this work, you may distribute the resulting work only under a licence identical to this one. For any reuse or distribution, you must make clear to others the licence terms of this work. Any of these conditions can be waived if you get permission from the copyright holder. -
Potential Drug Development Candidates for Human Soil- Transmitted Helminthiases
Potential Drug Development Candidates for Human Soil- Transmitted Helminthiases Piero Olliaro1*,Ju¨ rg Seiler2, Annette Kuesel1, John Horton3, Jeffrey N. Clark4, Robert Don5, Jennifer Keiser6,7 1 UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland, 2 ToxiConSeil, Riedtwil, Switzerland, 3 Tropical Projects, Hitchin, United Kingdom, 4 JNC Consulting Services LLC, Pittsboro, North Carolina, United States of America, 5 Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland, 6 Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland, 7 University of Basel, Basel, Switzerland Abstract Background: Few drugs are available for soil-transmitted helminthiasis (STH); the benzimidazoles albendazole and mebendazole are the only drugs being used for preventive chemotherapy as they can be given in one single dose with no weight adjustment. While generally safe and effective in reducing intensity of infection, they are contra-indicated in first- trimester pregnancy and have suboptimal efficacy against Trichuris trichiura. In addition, drug resistance is a threat. It is therefore important to find alternatives. Methodology: We searched the literature and the animal health marketed products and pipeline for potential drug development candidates. Recently registered veterinary products offer advantages in that they have undergone extensive and rigorous animal testing, thus reducing the risk, cost and time to approval for human trials. For selected compounds, we retrieved and summarised publicly available information (through US Freedom of Information (FoI) statements, European Public Assessment Reports (EPAR) and published literature). Concomitantly, we developed a target product profile (TPP) against which the products were compared. -
Anthelmintic Drugs
Anthelmintic Drugs By Dr. Nehal Aly Afifi Professor of Pharmacology Cairo university E-mail: [email protected] http://scholar.cu.edu.eg/prof-nehalafifi Dr. Nehal Afifi 2 4/11/2016 Types of Common Helminthes: 1. Worms live in hosts GIT. 2. Worms or larvae live in other tissues of hostsꞌ body like muscles , viscera , meninges , lungs, subcutaneous tissues. 1. Gastrointestinal worms A- TAPE WORMS (CESTODES) Taenia saginata (Beef) Taenia solium (Pork), Diphylobothrium latum (Fish) Humans infected by eating raw or under cooked meat containing larvae or encysted in infected animal muscles. Dr. Nehal Afifi 3 4/11/2016 1. Tapeworms (Cestodes) T. saginata (Beef tapeworm) T. solium (Pork tapeworm) Diphylobothrium latum (fish tape In case of D. latum infections by eating raw or undercooked fish Tapeworm In some conditions this larvae may develop causing cysticercosis (i.e. larvae gets encysted in muscle , or more seriously in brain or eye) cysticercosis Dr. Nehal Afifi 4 4/11/2016 Tapeworms in Small Animals Cestode Definitive Approved Host Treatments Dipylidium caninum Dog, Epsiprantel, cat Praziquantel Cat Taenia taeniaeformis Epsiprantel Praziquantel Fenbendazole Dr. Nehal Afifi 5 4/11/2016 Taenia Dog Hydatid tape worm Echinococcus granulosus . These are cestodes ,primary in canines (dogs) and sheep as intermediate host. Humans can act intermediate host in which larvae develop to hydatid cyst within the tissue. Hydateid cyct filariasis Dr. Nehal Afifi 6 4/11/2016 Life cycle of Echinococcus granulosus Dr. Nehal Afifi 7 4/11/2016 2- INTESTINAL ROUND WORMS (NEMATODES) 8 • Ascaris lmubricods (common round worm) • Enterobius vermicularis (pin worm) • Trichuris trichuria ( whip worm) • Strongyloids stercoralis ( thread worm) • Ankylostoma dudenale (hook worm) • B. -
A Bug's Life External and Internal Parasites of The
A BUG’S LIFE EXTERNAL AND INTERNAL PARASITES OF THE CAT & DOG Danielle J. Schaak, LVT, VTS (SAIM) Diagnostic Imaging Department Oakland Veterinary Referral Services 1400 S. Telegraph Rd Bloomfield Hills, MI 48302 A parasite is a smaller organism that lives in or on and at the expense of a larger organism. External Parasites: Demodex is a cigar like external parasite that has 4 pairs of stubby legs. It can be a normal finding in small numbers in most dogs. It is when it becomes large numbers due to an immunodeficiency that it becomes a problem. Demodex is usually acquired during the first three days of life during nursing. A Demodex infection typically occurs in puppies 3-6 months of age and also due to an immunodeficiency. These patients have erythema, alopecia around eyes and mouth. The lesions they have are localized and not typically pruritic. These patients can be treated with Amitraz, Benzyl Benzoate, Rotenone, Ronnel, Cythioate. Chronic cases need to be treated with oral Ivermectin. With this treatment, results are typically seen within 4 months. An alternative to Ivermectin is Milbemycin Oxime orally for 12 months. Sarcoptic mange is a zoonotic external parasite. It typically starts on a hairless area such as the ear pinna/elbows and then generalizes itself throughout the body. Causes follicular papules, erythema, pruritis as well as secondary bacterial infections. It can be very hard to diagnose; skin scrapings need to be very deep and can still be negative. Female mite burrows deep into epidermis to lay eggs which then take 21 days to hatch. -
Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods and Uses Thereof
(19) TZZ¥Z__T (11) EP 3 061 454 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 31.08.2016 Bulletin 2016/35 A61K 31/422 (2006.01) A61P 33/00 (2006.01) (21) Application number: 16163407.6 (22) Date of filing: 31.01.2013 (84) Designated Contracting States: (72) Inventors: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB • SOLL, Mark, D. GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO Alpharetta, GA Georgia 30005 (US) PL PT RO RS SE SI SK SM TR • LARSEN, Diane Designated Extension States: Buford, GA Georgia 30519 (US) BA ME • CADY, Susan, Mancini Yardley, PA Pennsylvania 19067 (US) (30) Priority: 06.02.2012 US 201261595463 P • CHEIFETZ, Peter East Windsor, NJ New Jersey 08520 (US) (62) Document number(s) of the earlier application(s) in • GALESKA, Izabela accordance with Art. 76 EPC: Newtown, PA Pennsylvania 18940 (US) 13703705.7 / 2 811 998 • GONG, Saijun Bridgewater, NJ New Jersey 08807 (US) (71) Applicant: Merial, Inc. Duluth, GA 30096 (US) (74) Representative: D Young & Co LLP 120 Holborn London EC1N 2DY (GB) (54) PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF (57) This invention relates to oral veterinary compo- methods for eradicating, controlling, and preventing par- sitions for combating ectoparasites and endoparasites in asite infections and infestations in an animal comprising animals, comprising at least one systemically-acting ac- administering the compositions of the invention to the tive agent in combination with a pharmaceutically accept- animal in need thereof. -
Praziquantel Resistance in the Zoonotic Cestode Dipylidium Caninum Jeba Jesudoss Chelladurai Iowa State University, [email protected]
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Digital Repository @ Iowa State University Veterinary Pathology Publications and Papers Veterinary Pathology 11-7-2018 Praziquantel Resistance in the Zoonotic Cestode Dipylidium caninum Jeba Jesudoss Chelladurai Iowa State University, [email protected] Tsegabirhan Kifleyohannes Mekelle University College of Veterinary Medicine Janelle Scott Colorado State University Matthew .T Brewer Iowa State University, [email protected] Follow this and additional works at: https://lib.dr.iastate.edu/vpath_pubs Part of the Veterinary Pathology and Pathobiology Commons, Veterinary Preventive Medicine, Epidemiology, and Public Health Commons, and the Veterinary Toxicology and Pharmacology Commons The ompc lete bibliographic information for this item can be found at https://lib.dr.iastate.edu/ vpath_pubs/105. For information on how to cite this item, please visit http://lib.dr.iastate.edu/ howtocite.html. This Article is brought to you for free and open access by the Veterinary Pathology at Iowa State University Digital Repository. It has been accepted for inclusion in Veterinary Pathology Publications and Papers by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Praziquantel Resistance in the Zoonotic Cestode Dipylidium caninum Abstract Dipylidium caninum is a cosmopolitan cestode infecting dogs, cats, and humans. Praziquantel is a highly effective cestocidal drug and resistance in adult cestodes has not been reported. From 2016 to 2018, a population of dogs with cestode infections that could not be eliminated despite multiple treatments with praziquantel or epsiprantel was identified. Cases of D. caninum were clinically resistant to praziquantel and could not be resolved despite increasing the dose, frequency, and duration of treatment.